Upstream Bio (UPB) Retained Earnings (2023 - 2026)
Upstream Bio (UPB) recorded quarterly Retained Earnings of $100000.0 in Q1 2026, down 81.13% quarter-over-quarter from $530000.0 in Q4 2025, and down 72.83% on a YoY basis from $368000.0 in Q1 2025.
Upstream Bio (UPB) Retained Earnings (2023 - 2026) Analysis & Trends
Upstream Bio's Retained Earnings history runs 4 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 72.83% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $100000.0 (down 72.83% YoY), while the FY2025 annual figure was $530000.0, up 100.28% from the prior year.
- Retained Earnings was $100000.0 for Q1 2026 at Upstream Bio, down from $530000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $530000.0 in Q4 2025 to a low of -$291.8 million in Q3 2025.
- Historically, Retained Earnings has averaged -$113.6 million across 4 years, with a median of -$84.7 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings slumped 908576.19% in 2024, then surged 100.28% in 2025.
- A 4-year view of Retained Earnings shows it stood at $21000.0 in 2023, then plunged by 908576.19% to -$190.8 million in 2024, then soared by 100.28% to $530000.0 in 2025, then slumped by 81.13% to $100000.0 in 2026.
- The last three Retained Earnings figures came in at $100000.0 (Q1 2026), $530000.0 (Q4 2025), and -$291.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Upstream Bio | 339.03 Mn | 339.03 Mn | -3.94 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 530,000.00 |
| Sep 30, 2025 | -291.76 Mn |
| Jun 30, 2025 | -258.00 Mn |
| Mar 31, 2025 | 368,000.00 |
| Dec 31, 2024 | -190.78 Mn |
| Sep 30, 2024 | -169.50 Mn |
| Dec 31, 2023 | 21,000.00 |